The Taxoids

@article{Eisenhauer2012TheT,
  title={The Taxoids},
  author={E. Eisenhauer and J. Vermorken},
  journal={Drugs},
  year={2012},
  volume={55},
  pages={5-30}
}
  • E. Eisenhauer, J. Vermorken
  • Published 2012
  • Medicine
  • Drugs
  • SummaryPaclitaxel and docetaxel are 2 compounds from the new taxoid class of anti-cancer agents. Both drugs are very similar in preclinical activity, mechanism of action and spectrum of clinical activity. Some subtle differences in the intracellular retention of docetaxel may account for its lack of schedule-related myelosuppression and greater potency, and may be relevant to the skin toxicity and oedema which it produces. Early data suggest that there may be differing behaviour of… CONTINUE READING
    36 Citations
    Pre-application of arsenic trioxide may potentiate cytotoxic effects of vinorelbine/docetaxel on neuroblastoma SK-N-SH cells.
    • Kai Qi, Y. Li, +4 authors Wenjun Weng
    • Chemistry, Medicine
    • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
    • 2019
    • 1
    Simultaneous online SPE-HPLC-MS/MS analysis of docetaxel, temsirolimus and sirolimus in whole blood and human plasma.
    • 33

    References

    SHOWING 1-10 OF 192 REFERENCES
    Preclinical evaluation of docetaxel (Taxotere).
    • 264
    Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer.
    • 123
    Phase I trial of taxol in patients with advanced cancer.
    • 178
    Activity of Docetaxel (Taxotere) in Small Cell Lung Cancer
    • 28
    A phase II trial of taxol in metastatic melanoma
    • 161
    Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.
    • 872
    Taxol: a review of its preclinical in vivo antitumor activity.
    • 125
    Paclitaxel plus carboplatin in the treatment of ovarian cancer.
    • 22